C3 and metabolic syndrome: Most available studies on complement and the metabolic syndrome are cross-sectional and mainly focused on C3 [9–11], the central component of the alternative pathway, and its degradation product C3a-desarg (also known as acylation-stimulating protein, ASP) [12, 13].